About Pharmaprojects...
Because it is an authoritative source and covers 40 countries, I think Pharmaprojects will be able to provide me with the additional licensing information that Sharon wants. I'll take a look at the file in detail.
Pharmaprojects is compiled from both published and unpublished sources. Published sources include press releases, annual reports, PuBMed abstracts, analysts meetings and conference abstracts. A considerable amount of information is obtained directly from the companies involved in product development.
In addition, Pharmaprojects staff attend international meetings to obtain information directly from research scientists. They also scan conference proceedings and the scientific and medical literature to track new products.
Additional key points about this file are:
- Contains extensive company information—originating company and development status, licensees and development status, and patent/priority data.
- Information provided in the form of 73 searchable fields including: drug name, synonyms, chemical name, chemical structure, CAS® Registry Number, rigorously classified therapeutic activity, molecular formula, and pharmacology data. Also present are indications, route of administration, and origin of material, as well as recently added fields for pharmacokinetics, drug protein target, Lipinsky “Rule of 5” data and latest update. Target family fields (e.g GPCR or kinase), NCE classifications and ability to search for future or current licensing opportunities were added in 2006 and 2007. Tip 3-1
- Identifies if a substance is a new chemical entity.
- New Target Data contains links to the Entrez Gene database from the U.S. National Center for Biotechnology Information (NCBI). In many records the link connects to an entry in the database for the gene whose product is targeted by the drug of record. New Pharmaprojects fields include searchable Target Data Codes (TG=, /TG) and Target Families ( /TF).
- Pharmaprojects offers indexing on major events in the drug’s development and provides a latest update field, which makes Pharmaprojects an excellent database to create Alerts to monitor progress
- File 128 is the public file; File 928 is the subscriber file, available to those who subscribe to the web Pharmaprojects.
- Covers 1980 to the present, for products in active development and those that have ceased development or launched in all their major markets.
- Updated weekly.
- Contains stage of development in up to 40 countries
- A linking (/lg) field shows the relationship between therapeutic indication, pharmacological activity and development status.
- Status and Indications fields allow the searcher to combine country and status and indications and status
Go to the next page.
